Matteo Levisetti

Matteo Levisetti

No más puestos en curso

Fortuna: 9 720 $ al 30/06/2026

57 años
Health Technology
Consumer Services
Commercial Services

Perfil

Matteo Levisetti worked as Executive Director-Clinical Development at Mirati Therapeutics, Inc. from 2016 to 2017.
Served as Chief Medical Officer at Dauntless Pharmaceuticals, Inc. from 2017 to 2018.
Held the position of Chief Medical Officer at DNAtrix, Inc. from 2019 to 2021.
Worked as Chief Medical Officer at Cue Biopharma, Inc. from 2023 to 2025.
Held the role of Global Head & VP-Translational Medicine at Roche Pharmaceuticals, Inc. Worked as Assistant Professor at Washington University School of Medicine.
Education includes a doctorate degree from Pritzker School of Medicine conferred in 1996.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
05/05/2026 308 ( 0,01 % ) 9 720 $ 30/06/2026

Antiguos cargos conocidos de Matteo Levisetti.

EmpresasCargoFin
CUE BIOPHARMA, INC. Director Técnico/Científico/I+D 28/11/2025
Director Técnico/Científico/I+D 01/01/2021
Director Técnico/Científico/I+D 01/06/2018
MIRATI THERAPEUTICS Director Técnico/Científico/I+D 01/05/2017
Corporate Officer/Principal -
Ver el detalle de la experiencia de Matteo Levisetti.

Formación de Matteo Levisetti.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

15

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Commercial Services

Electronic Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Retail Trade

  1. Bolsa de valores
  2. Insiders
  3. Matteo Levisetti